Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection

Affiliations

• ¹ The Francis Crick Institute, London, UK; University College London, London, UK.
• ² COVID Surveillance Unit, London, UK; The Francis Crick Institute, London, UK.
• ³ The Francis Crick Institute, London, UK; National Institute for Health Research University College London Hospitals Biomedical Research Centre and Clinical Research Facility, London, UK.
• ⁴ Worldwide Influenza Centre, London, UK.
• ⁵ The Francis Crick Institute, London, UK.
• ⁶ COVID Surveillance Unit, London, UK.
• ⁷ London Northwest University Healthcare NHS Trust, London, UK.
• ⁸ Central and North West London NHS Foundation Trust, London, UK.
• ⁹ The Francis Crick Institute, London, UK; Department of Infectious Disease, St Mary's Hospital, Imperial College London, London, UK.
• ¹⁰ University College London, London, UK; National Institute for Health Research University College London Hospitals Biomedical Research Centre and Clinical Research Facility, London, UK.
• ¹¹ The Francis Crick Institute, London, UK; University College London, London, UK; National Institute for Health Research University College London Hospitals Biomedical Research Centre and Clinical Research Facility, London, UK. Electronic address: emma.wall@crick.ac.uk.